eFFECTOR Therapeutics, Inc. (EFTR)
OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
At close: Sep 2, 2026
eFFECTOR Therapeutics Market Cap
eFFECTOR Therapeutics has a market cap or net worth of $3.76 thousand as of September 8, 2026. Its market cap has increased by 300.00% in one year.
Market Cap
3.76K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since March 1, 2021, eFFECTOR Therapeutics's market cap has decreased from 218.96M to 3.76K, a decrease of -100.00%. That is a compound annual growth rate of -86.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 3.76K | 300.00% |
| Dec 31, 2025 | 941.00 | - |
| Dec 31, 2024 | 941.00 | -100.00% |
| Dec 29, 2023 | 30.20M | 68.61% |
| Dec 30, 2022 | 17.91M | -94.64% |
| Dec 31, 2021 | 334.28M | 52.66% |
| Mar 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aridis Pharmaceuticals | 5.33K |
| MultiCell Technologies | 5.00K |
| Arno Therapeutics | 4.98K |
| Kaleido Biosciences | 4.26K |
| ONE Bio | 4.19K |
| Baseline Productions | 4.11K |
| EV Biologics | 4.09K |
| Xeno Transplants | 4.04K |